View All Documents & Correspondence
A Composition Comprising A Flavanone, And Metabolite Thereof And Uses Thereof
Abstract: The present disclosure relates to a composition comprising naringin and naringenin for inhibiting intracellular cholesterol, and to maintain general health and wellbeing by guarding against excessive cholesterol in cells.
Notices, Deadlines & Correspondence
Patent Information
Applicants
ITC LIMITED
Inventors
1. KUDTARKAR, Kavita Gopalkrishna
2. KS, Nandakumar
3. RADHAKRISHNAN, Yashwanth
4. CHANDRASEKHARAN, Lakshmanan Chittur
Specification
Claims:1. A composition comprising:
a. naringin; and
b. naringenin,
wherein naringin to naringenin w/w ratio in said composition is in the range of 1:0.5-1:5.
2. The composition as claimed in claim 1, wherein naringin weight percentage in said composition is in the range of 0.000025-0.0001%, and naringenin weight percentage in said composition is in the range of 0.00005-0.000125%.
3. The composition as claimed in claim 1, wherein naringin to naringenin w/w ratio in said composition is in the range of 1:0.66-1:4.
4. The composition as claimed in claim 3, wherein naringin weight percentage in said composition is in the range of 0.00003-0.00009%, and naringenin weight percentage in said composition is in the range of 0.00006-0.00012%.
5. The composition as claimed in claim 3, wherein naringin to naringenin w/w ratio in said composition is 1:0.66.
6. The composition as claimed in claim 5, wherein naringin weight percentage in said composition is 0.00009%, and naringenin weight percentage in said composition is 0.00006%.
7. The composition as claimed in claim 3, wherein naringin to naringenin w/w ratio in said composition is 1:1.
8. The composition as claimed in claim 7, wherein naringin weight percentage in said composition is 0.000075%, and naringenin weight percentage in said composition is 0.000075%.
9. The composition as claimed in claim 3, wherein naringin to naringenin w/w ratio in said composition is 1:1.5.
10. The composition as claimed in claim 9, wherein naringin weight percentage in said composition is 0.00006%, and naringenin weight percentage in said composition is 0.00009%.
11. The composition as claimed in claim 3, wherein naringin to naringenin w/w ratio in said composition is 1:4.
12. The composition as claimed in claim 11, wherein naringin weight percentage in said composition is 0.00003%, and naringenin weight percentage in said composition is 0.00012%.
13. The composition as claimed in any of the claims 1-12, further comprising carriers, diluents, and excipients.
14. A method of preparing a composition as claimed in any of the claims 1-13.
15. A method of inhibiting intracellular cholesterol, said method comprising:
a. obtaining a composition as claimed in any of the claims 1-13; and
b. contacting said composition with a cell comprising cholesterol,
wherein said method inhibits intracellular cholesterol.
Dated this April, 2016
, Description:As Attached
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | Form 5 [11-04-2016(online)].pdf | 2016-04-11 |
| 2 | Form 3 [11-04-2016(online)].pdf | 2016-04-11 |
| 3 | Drawing [11-04-2016(online)].pdf | 2016-04-11 |
| 4 | Description(Complete) [11-04-2016(online)].pdf | 2016-04-11 |
| 5 | Other Patent Document [26-05-2016(online)].pdf | 2016-05-26 |
| 6 | Form 26 [26-05-2016(online)].pdf | 2016-05-26 |
| 7 | 201641012731-FORM 18 [09-04-2020(online)].pdf | 2020-04-09 |
| 8 | 201641012731-FER.pdf | 2021-10-17 |
Search Strategy
| 1 | search201641012731E_22-09-2020.pdf |